Micin vs Idexx Laboratories
Side-by-side comparison of AI visibility scores, market position, and capabilities
MICIN raised 10B+ yen (~$99M) through Series C; its Curon telemedicine platform serves 5,000+ Japan clinics; digital therapeutics and clinical development tools round out a multi-pillar health tech platform.
About
MICIN is a Tokyo-based healthcare technology company founded in 2015 that operates at the intersection of telemedicine, digital therapeutics, and clinical development. Its flagship platform, Curon, enables online medical consultations — allowing patients in Japan to book appointments, receive virtual consultations, pay, and receive prescription delivery entirely online. Launched in 2016, Curon is now used by more than 5,000 clinics and hospitals across Japan.
Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.
About
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.